產(chǎn)品詳情
簡單介紹：
Anti-RFPL2+RFPL3抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-RFPL2+RFPL3抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-RFPL2+RFPL3
Cat. Number:
Anti-RFPL2+RFPL3抗體KL-8493R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The RFPL3 protein is 371 amino acids long and may have been emerged due to intrachromosomal duplication.RFPL1, RFPL2 and RFPL3 (ret finger protein-like 1, 2 and 3, respectively), exist as a cluster of genes mapping toAnti-RFPL2+RFPL3抗體 human chromosome 22q12.2-q13.3, sharing 95%-96% identity. RFPL1, 2 and 3, are thought to contribute to neocortex organization and size in primates, and show high expression in fetal neocortex as well as embryonic stem-cell neurogenesis. Each of the three RFPL genes encodes two exons giving rise to a putative RING-like motifs and B30-2 domains. RFPL1, also known as RNF78 or MGC132428, is a 317 amino acid protein known to have high expression in prostate with lower expression in ***** brain, fetal liver and fetal kidney. RFPL2, or RNF79, is 378 amino acids long and is also highly expressed in prostate with lower expression in fetal kidney and fetal liver. As a result of alternative splicing, three isoforms of RFPL2 exist.
Also known as:
RFPL2 + RFPL3; Ret fingerAnti-RFPL2+RFPL3抗體 protein like 3; ret finger protein-like 3; RFPL 3; RFPL3; RFPL-3; RFPL2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugatedAnti-RFPL2+RFPL3抗體 synthetic peptide derived from human RFPL3.
●
Predicted Molecular Weight: 42kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-RFPL2+RFPL3抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-RFPL2+RFPL3抗體
Optimal working dilutions must be determined by the end user.
